Previous 10 | Next 10 |
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to present the FY21 Annual Report to Shareholders. FY21 was a productive year for the Company, culiminating in a successful Initial Public Offering (IPO) raising equity of approximately $2,500,000 throug...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that eminent hepatologist, Professor Darrell H.G. Crawford, has been appointed to its Scientific Advisory Board (SAB). Dr David Kingston, the Chief Scientific Officer and Chair of the Scienti...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd, has appointed Gallipoli Medical Research Foundation (GMRF) as a clinical study site for its multi-site Phase II Clinical Study in Non-Alcoh...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that it's operational subsidiary, Invictus Ops Pty Ltd., has approved a clinical study protocol for a clinical study to be conducted by Altipure R&D in Ohio, USA on its patented nutraceutical...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has agreed with FIFO Capital to renew a Receivable Finance Facility with respect to VTL's assessed tax cash benefit under the Federal Government's R&D Tax Incentive Program administer...
Sydney, Australia (ABN Newswire) - Invictus Nutraceuticals, Inc. (Florida, USA), a wholly owned subsidiary of VGI Health Technology Limited (NSX:VTL), is pleased to announce that it has partnered with Informed Sport to certify its NE1-Elite(R) product. Informed Sport certified products pr...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) recently signed a manufacturing and supply agreement with a US manufacturer, Altipure LLC, for finished nutraceutical products for sale and clinical study drugs for our clinical studies. Altipure LLC was introduced to ...
Sydney, Australia (ABN Newswire) - Further to Azure Health Technology Limited's (NSX:VTL) announcement on 16 March 2021 that the first manufacturing run for our finished nutraceutical products has been completed, Azure Health Technology Limited trading as VGI Health Technology (the Company or...
Sydney, Australia (ABN Newswire) - Azure Health Technology Limited (NSX:VTL) trading as VGI Health Technology is pleased to announce that Pitt Street Research has issued an Initiation Report. VTL's CEO and Managing Director, Dr Glenn Tong, said that the founder and senior analyst of Pitt ...
Sydney, Australia (ABN Newswire) - Azure Health Technology Limited trading as VGI Health Technology (NSX:VTL) is pleased to announce that an additional current Good Manufacturing Practice (cGMP) manufacturer has been appointed in the US. VTL has executed a Manufacturing and Supply Agreeme...
News, Short Squeeze, Breakout and More Instantly...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has entered into a non-binding Heads of Agreement with Hebei Visual Medical Technology Co. Ltd (HVMT), marking a significant step in VTL's distribution strategy into the market of the People'...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has received human ethics approval from the Human Research Ethics Committee of The Peter MacCallum Cancer Centre for its Phase II cl...
Sydney, Australia (ABN Newswire) - VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has been advised by Invictus BioPharma Holdings Ltd (IVBHL) that IVBHL is now in a position to commence the process of acquiring Invictus BioPharma Pty Ltd in accordance with the Share Sale A...